Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margaret C Grabb

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of the American Academy of Child and Adolescent Psychiatry|November 4, 2017
Paving the Way for Assessing Novel Pediatric Interventions in PsychiatryMargaret C Grabb
Journal of Clinical Psychopharmacology|April 30, 2022
Central Nervous System Trial Failures: Using the Fragile X Syndrome-mGluR5 Drug Target to Highlight the Complexities of Translating Preclinical Discoveries Into Human TrialsMargaret C Grabb, William Z Potter
Advances in Neurobiology|November 19, 2024
Biomarker Methodologies: A NIMH PerspectiveMargaret C Grabb, Linda S Brady
Progress in Neurobiology|May 25, 2016
Challenges in developing drugs for pediatric CNS disorders: A focus on psychopharmacologyMargaret C Grabb, Jogarao V S Gobburu
Pharmaceutical Medicine|July 25, 2020
The NIMH 'Fast-Fail Trials' (FAST) Initiative: Rationale, Promise, and ProgressMargaret C Grabb, Mi Hillefors, William Z Potter
Journal of Clinical Psychopharmacology|July 13, 2016
Derisking Psychiatric Drug Development: The NIMH's Fast Fail Program, A Novel Precompetitive ModelMargaret C Grabb, Alan J Cross, William Z Potter, et al.
Journal of Clinical Pharmacology|June 29, 2021
A Call for Objective Dose Selection to Increase Success in Pediatric Clinical Trials: A Perspective From NICHD and NIMH Program StaffGeorge Giacoia, Margaret C Grabb, Aaron C Pawlyk, et al.
Neurobiology of Disease|April 2, 2004
Raising intracellular calcium attenuates neuronal apoptosis triggered by staurosporine or oxygen-glucose deprivation in the presence of glutamate receptor blockadeLorella M T Canzoniero, Debra J Babcock, Frank J Gottron, et al.
Innovations in Clinical Neuroscience|March 18, 2024
Ensuring Stakeholder Feedback in the Design and Conduct of Clinical Trials for Rare Diseases: ISCTM Position Paper of the Orphan Disease Working GroupGahan J Pandina, Joan Busner, Lucas Kempf, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of the American Academy of Child and Adolescent Psychiatry|November 4, 2017
Paving the Way for Assessing Novel Pediatric Interventions in PsychiatryMargaret C Grabb
Journal of Clinical Psychopharmacology|April 30, 2022
Central Nervous System Trial Failures: Using the Fragile X Syndrome-mGluR5 Drug Target to Highlight the Complexities of Translating Preclinical Discoveries Into Human TrialsMargaret C Grabb, William Z Potter
Advances in Neurobiology|November 19, 2024
Biomarker Methodologies: A NIMH PerspectiveMargaret C Grabb, Linda S Brady
Progress in Neurobiology|May 25, 2016
Challenges in developing drugs for pediatric CNS disorders: A focus on psychopharmacologyMargaret C Grabb, Jogarao V S Gobburu
Pharmaceutical Medicine|July 25, 2020
The NIMH 'Fast-Fail Trials' (FAST) Initiative: Rationale, Promise, and ProgressMargaret C Grabb, Mi Hillefors, William Z Potter
Journal of Clinical Psychopharmacology|July 13, 2016
Derisking Psychiatric Drug Development: The NIMH's Fast Fail Program, A Novel Precompetitive ModelMargaret C Grabb, Alan J Cross, William Z Potter, et al.
Journal of Clinical Pharmacology|June 29, 2021
A Call for Objective Dose Selection to Increase Success in Pediatric Clinical Trials: A Perspective From NICHD and NIMH Program StaffGeorge Giacoia, Margaret C Grabb, Aaron C Pawlyk, et al.
Neurobiology of Disease|April 2, 2004
Raising intracellular calcium attenuates neuronal apoptosis triggered by staurosporine or oxygen-glucose deprivation in the presence of glutamate receptor blockadeLorella M T Canzoniero, Debra J Babcock, Frank J Gottron, et al.
Innovations in Clinical Neuroscience|March 18, 2024
Ensuring Stakeholder Feedback in the Design and Conduct of Clinical Trials for Rare Diseases: ISCTM Position Paper of the Orphan Disease Working GroupGahan J Pandina, Joan Busner, Lucas Kempf, et al.
Pageof 1